FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

DASH Pharmaceuticals Sucralfate Oral Suspension Recall

Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups…

DASH Pharmaceuticals LLC · Upper Saddle River, NJ

Risk level
Class II
Reported by FDA
Apr 13, 2022
Recall ID
D-0749-2022
Check your lot numberHow we source this data

Summary

DASH Pharmaceuticals recalled Sucralfate Oral Suspension starting Mar 11, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0749-2022 on Apr 13, 2022. Reason: Labeling: Label Mix-Up. Status: Terminated.

Why it was recalled

Labeling: Label Mix-Up

Product description

Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.

Lot numbers, UPCs & expiration codes

Lot #: a) 376908P40, Exp. Date 02/28/2023; b) 376908P100, Exp. Date 02/28/2023

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0749-2022
Classification
Class II
Status
Terminated
Recall initiated
Mar 11, 2022
FDA report date
Apr 13, 2022
Quantity
45,940 Unit Dose Cups
Recall type
Voluntary: Firm initiated
Recalling firm
DASH Pharmaceuticals LLC

Original FDA data

Every field from FDA enforcement report D-0749-2022, exactly as published.

Show all FDA fields
City
Upper Saddle River
State
NJ
Status
Terminated
Country
United States
Event ID
89814
Address
2 Park Way
Code information
Lot #: a) 376908P40, Exp. Date 02/28/2023; b) 376908P100, Exp. Date 02/28/2023
Postal code
07458-2345
Report date
Apr 13, 2022
Product type
Drugs
Recall number
D-0749-2022
Classification
Class II
Recalling firm
DASH Pharmaceuticals LLC
Product quantity
45,940 Unit Dose Cups
Termination date
Feb 16, 2023
Reason for recall
Labeling: Label Mix-Up
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.
Distribution pattern
Nationwide within the United States
Recall initiation date
Mar 11, 2022
Initial firm notification
Letter
Center classification date
Apr 6, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0749-2022, published Apr 13, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls